Current discoveries on the cognitive effects of antiepileptic drugs (Q33999483)

30 July 2017

1 reference

title

Current discoveries on the cognitive effects of antiepileptic drugs (English)

1 reference

30 July 2017

Meador KJ

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 August 2000

1 reference

30 July 2017

1 reference

30 July 2017

1 reference

30 July 2017

issue

8 Pt 2

1 reference

30 July 2017

page(s)

185S-190S

1 reference

Mental deterioration in epilepsy

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.185S.35253

Cognitive side-effects of chronic antiepileptic drug treatment: a review of 25 years of research

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.185S.35253

Effect of gabapentin (Neurontin) [corrected] on mood and well-being in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.185S.35253

Serum anticonvulsant concentrations in epileptic patients with mental symptoms. A preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.185S.35253

Reduction in polypharmacy for epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.185S.35253

Anticonvulsant serum levels: relationship to impairments of cognitive functioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.185S.35253

Effects of carbamazepine and phenytoin on EEG and memory in healthy adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.185S.35253

Effect of valproate on cognitive functioning. Comparison with carbamazepine. The Department of Veterans Affairs Epilepsy Cooperative Study 264 Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.185S.35253

Impact of valproate and phenytoin on cognitive function in elderly patients: results of a single-blind randomized comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.185S.35253

Phenobarbital for febrile seizures--effects on intelligence and on seizure recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.185S.35253

Developmental neurotoxicity of anticonvulsants: human and animal evidence on phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.185S.35253

Parental epilepsy, anticonvulsant drugs, and reproductive outcome: epidemiologic and experimental findings spanning three decades; 1: Animal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.185S.35253

Developmental toxicity of antiepileptic drugs: relationship to postnatal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.185S.35253

Parental epilepsy, anticonvulsant drugs, and reproductive outcome: epidemiologic and experimental findings spanning three decades; 2: Human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.185S.35253

Gabapentin and cognition: a double blind, dose ranging, placebo controlled study in refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.185S.35253

Differential cognitive effects of carbamazepine and gabapentin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.185S.35253

Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.185S.35253

Lamotrigine (BW430C), a potential anticonvulsant. Effects on the central nervous system in comparison with phenytoin and diazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.185S.35253

Carbamazepine and lamotrigine in healthy volunteers: relevance to early tolerance and clinical trial dosage

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.185S.35253

Standardisation of a self-report questionnaire for use in evaluating cognitive, affective and behavioural side-effects of anti-epileptic drug treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.185S.35253

Intractable epilepsy in children. The efficacy of lamotrigine treatment, including non-seizure-related benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.185S.35253

The efficacy of lamotrigine on seizure control in 34 children, adolescents and young adults with intellectual and physical disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.185S.35253

Oxcarbazepine. A review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.185S.35253

A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.185S.35253

Cognitive effects of oxcarbazepine and phenytoin monotherapy in newly diagnosed epilepsy: one year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.185S.35253

Memory and psychomotor effects of oxcarbazepine in healthy human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.185S.35253

Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.185S.35253

Neuropsychological effects of tiagabine, a potential new antiepileptic drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.185S.35253

Cognitive and quality of life effects of differing dosages of tiagabine in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.185S.35253

Effects of tiagabine monotherapy on abilities, adjustment, and mood

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.185S.35253

Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.185S.35253

Evaluation of the effects of vigabatrin on cognitive abilities and quality of life in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.185S.35253

Effects of differing dosages of vigabatrin (Sabril) on cognitive abilities and quality of life in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.185S.35253

Effect of vigabatrin on sedation and cognitive function in patients with refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.185S.35253

Effects of vigabatrin on partial seizures and cognitive function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.185S.35253

Psychophysiological and psychometric studies after manipulating the GABA system by vigabatrin, a GABA-transaminase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.185S.35253

Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy. A randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.185S.35253

Zonisamide (CI-912) and cognition: results from preliminary study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.185S.35253

Results of a nationwide Veterans Administration Cooperative Study comparing the efficacy and toxicity of carbamazepine, phenobarbital, phenytoin, and primidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.185S.35253

10.1592/PHCO.20.12.185S.35253

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference